InvestorsObserver
×
News Home

Analyst Rating: Will TherapeuticsMD Inc (TXMD) Stock Lead the Market?

Monday, August 01, 2022 12:43 PM | InvestorsObserver Analysts

Mentioned in this article

Analyst Rating: Will TherapeuticsMD Inc (TXMD) Stock Lead the Market?

InvestorsObserver is giving TherapeuticsMD Inc (TXMD) an Analyst Rating Rank of 5, meaning TXMD is ranked higher by analysts than 5% of stocks. The average price target for TXMD is $1 and analyst’s rate the stock as a Hold.

Overall Score - 3
Wall Street analysts are rating TXMD a Hold today. Find out what this means to you and get the rest of the rankings on TXMD!

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With TherapeuticsMD Inc Stock Today?

TherapeuticsMD Inc (TXMD) stock is trading at $7.77 as of 12:42 PM on Monday, Aug 1, an increase of $1.54, or 24.64% from the previous closing price of $6.23. The stock has traded between $6.80 and $8.43 so far today. Volume today is elevated. So far 2,714,834 shares have traded compared to average volume of 963,666 shares. Click Here to get the full Stock Report for TherapeuticsMD Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App